NEW YORK, NY / ACCESSWIRE / September 13, 2021 / Jakubowitz Regulation declares that securities fraud class motion lawsuits have commenced on behalf of shareholders of the next publicly-traded firms who bought shares throughout the class durations listed beneath. Shareholders desirous about representing the category of wronged shareholders have till the lead plaintiff deadline to petition the court docket. Your potential to share in any restoration doesn’t require that you simply function a lead plaintiff. For extra particulars and to talk with our agency with out price or obligation, comply with the hyperlinks beneath.
AdaptHealth Corp. f/ok/a DFB Healthcare Acquisitions Corp. (NASDAQ:AHCO)
CONTACT JAKUBOWITZ ABOUT AHCO:
Class Interval : November 11, 2019 – July 16, 2021
Lead Plaintiff Deadline : September 27, 2021
The filed grievance alleges that defendants made materially false and/or deceptive statements and/or did not disclose that: (i) AdaptHealth had misrepresented its natural development trajectory by retroactively inflating previous natural development numbers with out disclosing the modifications, in violation of Securities and Change Fee rules; (ii) accordingly, the Firm had materially overstated its monetary prospects; and (iii) consequently, the Firm’s public statements had been materially false and deceptive in any respect related occasions.
ATI Bodily Remedy, Inc. f/ok/a Fortress Worth Acquisition Corp. II (NYSE:ATIP)
CONTACT JAKUBOWITZ ABOUT ATIP:
This lawsuit is on behalf of buyers who: (a) bought or in any other case acquired ATI securities between April 1, 2021 and July 23, 2021, inclusive and/or (b) held FVAC Class A standard inventory as of Might 24, 2021 and had been eligible to vote at FVAC’s June 15, 2021 particular assembly.
Lead Plaintiff Deadline : October 15, 2021
The filed grievance alleges that defendants made materially false and/or deceptive statements and/or did not disclose that: (1) ATI was experiencing attrition amongst its bodily therapists; (2) ATI confronted growing competitors for clinicians within the labor market; (3) on account of the foregoing, the Firm confronted difficulties retaining therapists and incurred elevated labor prices; (4) on account of the labor scarcity, the Firm would open fewer new clinics; and (5) on account of the foregoing, Defendants’ constructive statements concerning the Firm’s enterprise, operations, and prospects had been materially deceptive and/or lacked an affordable foundation.
View, Inc. f/ok/a CF Finance Acquisition Corp. II (NASDAQ:VIEW)
CONTACT JAKUBOWITZ ABOUT VIEW:
Class Interval : November 30, 2020 – August 16, 2021
Lead Plaintiff Deadline : October 18, 2021
The filed grievance alleges that defendants made materially false and/or deceptive statements and/or did not disclose that: (1) View had not correctly accrued guarantee prices associated to its product; (2) there was a cloth weak spot in View’s inside controls over accounting and monetary reporting associated to guarantee accrual; (3) consequently, the Firm’s monetary outcomes for prior durations had been misstated; and (4) on account of the foregoing, Defendants’ constructive statements concerning the Firm’s enterprise, operations, and prospects had been materially deceptive and/or lacked an affordable foundation.
Jakubowitz Regulation is vigorous in pursuit of justice for shareholders who’ve been the sufferer of securities fraud. Legal professional promoting. Prior outcomes don’t assure comparable outcomes.
1140 Avenue of the Americas
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Regulation
View supply model on accesswire.com: